17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions

Jump to navigation Jump to search
Line 42: Line 42:


==Treatment==
==Treatment==
[[17-beta-hydroxysteroid dehydrogenase deficiency medical therapy|Medical Therapy]] | [[17-beta-hydroxysteroid dehydrogenase deficiency surgery|Surgery]] | [[17-beta-hydroxysteroid dehydrogenase deficiency primary prevention|Primary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention|Secondary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies|Future or Investigational Therapies]]
[[17-beta-hydroxysteroid dehydrogenase deficiency medical therapy|Medical Therapy]] | [[17-beta-hydroxysteroid dehydrogenase deficiency primary prevention|Primary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention|Secondary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==

Revision as of 15:16, 19 September 2012

17-beta-hydroxysteroid dehydrogenase deficiency
OMIM 264300
DiseasesDB 32638

For patient information, click here

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency

17-beta-hydroxysteroid dehydrogenase deficiency in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753


Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:WikiDoc Sources